All Pathways
Emergency MedicineEmergency

Lower GI Bleeding Management (ACG 2023)

Lower GI Bleeding Management (ACG 2023): START: Acute Lower GI Bleeding → Initial Assessment & Resuscitation → Hemodynamically Stable? → Hemodynamically...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    START: Acute Lower GI Bleeding

    Hematochezia or maroon stool

    1. Action

      Initial Assessment & Resuscitation

      Stabilize patient

      • 2 large-bore IVs
      • Type and screen/crossmatch
      • CBC, BMP, coags, LFTs
      • Rectal exam to confirm hematochezia
      • Consider NG tube/EGD if brisk bleeding (r/o upper source)
      1. Decision

        Hemodynamically Stable?

        Assess stability

        • UNSTABLE: SBP <90, HR >100, signs of shock
        • STABLE: Normal vitals, no active bleeding
        1. Warning

          Hemodynamically Unstable

          Aggressive resuscitation

          • Crystalloid resuscitation
          • Blood transfusion (target Hgb ≥7, or ≥8 if CAD)
          • Consider massive transfusion if ongoing
          • Correct coagulopathy
          • Rule out upper GI source with NG aspirate or EGD
          1. Decision

            Colonoscopy Timing

            Based on risk and stability

            • URGENT (<24h): Hemodynamic instability, high-risk features
            • ELECTIVE (24-72h): Stable, low-risk patients
            1. Action

              Bowel Preparation

              Prep before colonoscopy

              • Polyethylene glycol-based prep (4-6L over 3-4 hrs)
              • NG tube if unable to tolerate oral
              • Adequate prep improves diagnostic yield
              1. Action

                Colonoscopy

                Diagnostic and therapeutic

                • Identify bleeding source
                • Common sources: Diverticulosis, angiodysplasia, hemorrhoids, neoplasm, colitis
                • Endoscopic therapy if active bleeding or stigmata
                1. Decision

                  Bleeding Source Identified?

                  Colonoscopy findings

                  1. Action

                    Endoscopic Therapy

                    If active bleeding or stigmata

                    • Clips, thermal coagulation, or injection
                    • Combination therapy for high-risk lesions
                    • Tattoo lesion for localization if surgery needed
                    1. Decision

                      Rebleeding?

                      Monitor for recurrence

                      1. Warning

                        Angiography or Surgery

                        For refractory bleeding

                        • CTA to localize if bleeding rate >0.5 mL/min
                        • Angioembolization if source identified
                        • Surgery if angiography fails or unavailable
                      2. Outcome

                        Discharge

                        Stable, no rebleeding

                        • Address underlying cause
                        • Review anticoagulation/antiplatelet
                        • GI follow-up
                        • Return precautions
                  2. Action

                    No Source Identified

                    Further workup

                    • If ongoing bleeding: CT angiography or tagged RBC scan
                    • Capsule endoscopy for occult/obscure bleeding
                    • Consider upper endoscopy if not done
        2. Action

          Risk Stratification

          Identify high-risk features

          • Oakland Score recommended
          • HIGH RISK: Hemodynamic instability, ongoing bleeding, Hgb <7, comorbidities, anticoagulation
          • LOW RISK: Oakland ≤8, no high-risk features
          1. Action

            Low Risk (Oakland ≤8)

            May consider outpatient management

            • Outpatient colonoscopy within 7 days
            • Discharge with clear instructions
            • Return if recurrent bleeding

Guideline Source

ACG Clinical Guideline: Management of Patients With Acute Lower GI Bleeding 2023

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address obscure GI bleeding in detail
  • Risk stratification should be formalized with validated scores
  • Colonoscopy timing depends on local resources
  • Anticoagulation management requires multidisciplinary input

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

US: ACG 2023 is current standard

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Lower GI Bleeding Management (ACG 2023)?

The Lower GI Bleeding Management (ACG 2023) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on ACG Clinical Guideline: Management of Patients With Acute Lower GI Bleeding 2023.

What guideline is the Lower GI Bleeding Management (ACG 2023) based on?

This algorithm is based on ACG Clinical Guideline: Management of Patients With Acute Lower GI Bleeding 2023 (DOI: 10.14309/ajg.0000000000002297).

What are the limitations of the Lower GI Bleeding Management (ACG 2023)?

Known limitations include: Does not address obscure GI bleeding in detail; Risk stratification should be formalized with validated scores; Colonoscopy timing depends on local resources; Anticoagulation management requires multidisciplinary input. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Lower GI Bleeding Management (ACG 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free